ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2017

Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).

Takuya Awata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.